Melinda L. Telli, M.D.
Publication Details
-
Left ventricular dysfunction in patients receiving cardiotoxic cancer therapies are clinicians responding optimally?
J Am Coll Cardiol. 2010; (20): 1644-50
The purpose of this study was to examine treatment practices for cancer therapy-associated decreased left ventricular ejection fraction (LVEF) detected on echocardiography and whether management was consistent with American College of Cardiology/American Heart Association guidelines.
Help
Trial Administration